{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:38:44Z","timestamp":1794368324884,"version":"4.9.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Graduate Innovation Project of Shanxi Province","award":["2022Y726"],"award-info":[{"award-number":["2022Y726"]}]},{"name":"Graduate Innovation Project of Shanxi Province","award":["2022Y726"],"award-info":[{"award-number":["2022Y726"]}]},{"DOI":"10.13039\/100017949","name":"Health Commission of Shanxi Province","doi-asserted-by":"crossref","award":["2019138"],"award-info":[{"award-number":["2019138"]}],"id":[{"id":"10.13039\/100017949","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Innovation Team Project of Changzhi Medical College","award":["CX202001"],"award-info":[{"award-number":["CX202001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Esophageal squamous cell carcinoma (ESCC) is a high-risk malignant tumor that has been reported in China. Some studies indicate that gut microbiota disorders can affect the occurrence and development of ESCC, but the underlying mechanism remains unclear. In this study, we aimed to explore the possible underlying mechanisms using microbiomics and metabolomics. Fifty ESCC patients and fifty healthy controls were selected as the study subjects according to sex and age, and fecal samples were collected. 16S rDNA sequencing and LC\u2012MS were used for microbiomics and nontargeted metabolomics analyses. We found significant differences in the composition of the gut microbiota and metabolites between the ESCC patients and control individuals (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). ESCC patients exhibited increased abundances of Fusobacteriaceae and Lactobacillus, increased levels of GibberellinA34 and decreased levels of 12-hydroxydodecanoic acid; these metabolites could be diagnostic and predictive markers of ESCC. An increase in the abundance of Enterobacteriaceae and Lactobacillus significantly reduced the content of L-aspartate and pantothenic acid, which may be involved in the occurrence and development of ESCC by downregulating the expression of proteins in the pantothenate and coenzyme A biosynthesis pathways. An imbalance in the intestinal flora may decrease the number of eosinophils in peripheral blood, resulting in the activation of an inflammatory response and immune dysfunction, leading to ESCC deterioration. We hypothesize that this imbalance in the gut microbiota can cause an imbalance in intestinal metabolites, which can activate carcinogenic metabolic pathways, affect inflammation and immune function, and play a role in the occurrence and development of ESCC.<\/jats:p>","DOI":"10.1186\/s12885-024-11982-8","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T13:02:33Z","timestamp":1708606953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma\u2014\u2014based on microbiomics and metabolomics"],"prefix":"10.1186","volume":"24","author":[{"given":"Xingqiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqian","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"issue":"1","key":"11982_CR1","first-page":"22","volume":"39","author":"SM FENG R M, ZONG Y N, CAO","year":"2019","unstructured":"Feng R M, Zong Y N, Cao S M, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer statistics? [J]. Cancer Commun (Lond). 2019;39(1):22.","journal-title":"Cancer Commun (Lond)"},{"issue":"9","key":"11982_CR2","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/ijc.34158","volume":"151","author":"S WANG","year":"2022","unstructured":"Wang S, Zheng R, Arnold M, et al. Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype [J]. Int J Cancer. 2022;151(9):1447\u201361.","journal-title":"Int J Cancer"},{"issue":"2","key":"11982_CR3","first-page":"360","volume":"154","author":"M ABNET C C, ARNOLD","year":"2018","unstructured":"Abnet C C, Arnold M, Wei WQ. Epidemiol esophageal squamous cell carcinoma [J] Gastroenterol. 2018;154(2):360\u201373.","journal-title":"Epidemiol Esophageal Squamous Cell Carcinoma [J] Gastroenterol"},{"issue":"2","key":"11982_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s13402-020-00573-x","volume":"44","author":"CHEN M F","year":"2021","unstructured":"Chen M F, Lu M S, Hsieh C C, et al. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma [J]. Cell Oncol (Dordr). 2021;44(2):373\u201384.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"11982_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/prd.12425","volume":"89","author":"RJ LAMONT","year":"2022","unstructured":"Lamont Rj, Fitzsimonds Z R, Wang H, et al. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma [J]. Periodontol 2000. 2022;89(1):154\u201365.","journal-title":"Periodontol 2000"},{"issue":"11","key":"11982_CR6","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1002\/ijc.34458","volume":"152","author":"H SIMBA","year":"2023","unstructured":"Simba H, Mmbaga B T Menyad, et al. The contribution of smoking and smokeless tobacco to oesophageal squamous cell carcinoma risk in the African oesophageal cancer corridor: results from the ESCCAPE multicentre case-control studies [J]. Int J Cancer. 2023;152(11):2269\u201382.","journal-title":"Int J Cancer"},{"issue":"6","key":"11982_CR7","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","volume":"13","author":"T UHLENHOPP D J, THEN E O, SUNKARA","year":"2020","unstructured":"Uhlenhopp D J, Then E O, Sunkara T, et al. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors [J]. Clin J Gastroenterol. 2020;13(6):1010\u201321.","journal-title":"Clin J Gastroenterol"},{"key":"11982_CR8","doi-asserted-by":"crossref","unstructured":"Kamangar F, Nasrollahzadeh D. Safiri S, et al. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017 [J]. The Lancet Gastroenterology & Hepatology; 2020;5(6):582\u201397.","DOI":"10.1016\/S2468-1253(20)30007-8"},{"issue":"1","key":"11982_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/carcin\/bgab087","volume":"43","author":"Y SONOHARA","year":"2022","unstructured":"Sonohara Y, Takatsuka R, Masutani C, et al. Acetaldehyde induces NER repairable mutagenic DNA lesions [J]. Carcinogenesis. 2022;43(1):52\u20139.","journal-title":"Carcinogenesis"},{"issue":"2","key":"11982_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ijc.33421","volume":"149","author":"CS YANG","year":"2021","unstructured":"Yang C S, Chen X L. Research on esophageal cancer: with personal perspectives from studies in China and Kenya [J]. Int J Cancer. 2021;149(2):264\u201376.","journal-title":"Int J Cancer"},{"issue":"1","key":"11982_CR11","doi-asserted-by":"publisher","first-page":"17249","DOI":"10.1038\/s41598-017-17617-2","volume":"7","author":"X YANG","year":"2017","unstructured":"Yang X, Chen X, Zhuang M, et al. Smoking and alcohol drinking in relation to the risk of esophageal squamous cell carcinoma: a population-based case-control study in China [J]. Sci Rep. 2017;7(1):17249.","journal-title":"Sci Rep"},{"issue":"1","key":"11982_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41430-022-01194-3","volume":"77","author":"Y ZHAO","year":"2023","unstructured":"Zhao Y, Zhao W, Li J, et al. Effect of dietary consumption on the survival of esophageal squamous cell carcinoma: a prospective cohort study [J]. Eur J Clin Nutr. 2023;77(1):55\u201364.","journal-title":"Eur J Clin Nutr"},{"issue":"6","key":"11982_CR13","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/s41416-022-01890-8","volume":"127","author":"G MASUKUME","year":"2022","unstructured":"Masukume G, Mmbaga B T, Dzamalala C P, et al. A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case-control studies [J]. Br J Cancer. 2022;127(6):1106\u201315.","journal-title":"Br J Cancer"},{"key":"11982_CR14","doi-asserted-by":"crossref","unstructured":"Li S, Ye J, Lin Z Et al. Dietary inflammatory nutrients and esophageal squamous cell carcinoma risk: a case-control study [J]. Nutrients, 2022;14(23).","DOI":"10.3390\/nu14235179"},{"key":"11982_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2022.01.014","volume":"530","author":"D NOMOTO","year":"2022","unstructured":"Nomoto D, Baba Y, Liu Y, et al. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1\/RIPK2\/NF-kappaB pathway [J]. Cancer Lett. 2022;530:59\u201367.","journal-title":"Cancer Lett"},{"issue":"1","key":"11982_CR16","doi-asserted-by":"publisher","first-page":"2197836","DOI":"10.1080\/19490976.2023.2197836","volume":"15","author":"JW ZHANG","year":"2023","unstructured":"Zhang Jw, Yin H S Zhangd, et al. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway [J]. Gut Microbes. 2023;15(1):2197836.","journal-title":"Gut Microbes"},{"key":"11982_CR17","doi-asserted-by":"crossref","unstructured":"Lei J, Xu F, Deng C et al. Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL-32\/PRTN3 expression [J]. Cancer Sci, 2023.","DOI":"10.1111\/cas.15787"},{"issue":"2","key":"11982_CR18","doi-asserted-by":"publisher","first-page":"e0275922","DOI":"10.1128\/spectrum.02759-22","volume":"11","author":"N DING","year":"2023","unstructured":"Ding N, Cheng Y, Liu H, et al. Fusobacterium nucleatum infection induces malignant proliferation of esophageal squamous cell Carcinoma Cell by Putrescine production [J]. Microbiol Spectr. 2023;11(2):e0275922.","journal-title":"Microbiol Spectr"},{"issue":"7962","key":"11982_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-023-06081-w","volume":"617","author":"R NAGHAVIAN","year":"2023","unstructured":"Naghavian R, Faigle W. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma [J]. Nature. 2023;617(7962):807\u201317.","journal-title":"Nature"},{"key":"11982_CR20","doi-asserted-by":"crossref","unstructured":"Zhang Q, Zhao Q, Li T et al. Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity [J]. Cell Metab, 2023.","DOI":"10.1016\/j.cmet.2023.04.015"},{"issue":"10","key":"11982_CR21","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/jgh.15941","volume":"37","author":"S CHEUNG M K, YUE G G L, LAUW","year":"2022","unstructured":"Cheung M K, Yue G G L, Lauw S, et al. Alterations in gut microbiota of esophageal squamous cell carcinoma patients [J]. J Gastroenterol Hepatol. 2022;37(10):1919\u201327.","journal-title":"J Gastroenterol Hepatol"},{"issue":"8","key":"11982_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s11274-021-03086-3","volume":"37","author":"W SHEN","year":"2021","unstructured":"Shen W, Tang D, Deng Y, et al. Association of gut microbiomes with lung and esophageal cancer: a pilot study [J]. World J Microbiol Biotechnol. 2021;37(8):128.","journal-title":"World J Microbiol Biotechnol"},{"issue":"30","key":"11982_CR23","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3748\/wjg.v28.i30.4053","volume":"28","author":"QUAGLIO A E V","year":"2022","unstructured":"Quaglio A E V, Grillo T G, De Oliveira E C, S, et al. Gut microbiota, inflammatory bowel disease and colorectal cancer [J]. World J Gastroenterol. 2022;28(30):4053\u201360.","journal-title":"World J Gastroenterol"},{"key":"11982_CR24","doi-asserted-by":"publisher","first-page":"599734","DOI":"10.3389\/fcimb.2021.599734","volume":"11","author":"Y MA","year":"2021","unstructured":"Ma Y, Zhang Y, Xiang J, et al. Metagenome analysis of intestinal bacteria in healthy people, patients with inflammatory bowel disease and colorectal cancer [J]. Front cell infect microbiol. 2021;11:599734.","journal-title":"Front Cell Infect Microbiol"},{"key":"11982_CR25","doi-asserted-by":"publisher","first-page":"106939","DOI":"10.1016\/j.intimp.2020.106939","volume":"88","author":"L LI","year":"2020","unstructured":"Li L, Yu R, Cai T, et al. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment [J]. Int Immunopharmacol. 2020;88:106939.","journal-title":"Int Immunopharmacol"},{"key":"11982_CR26","doi-asserted-by":"publisher","first-page":"107451","DOI":"10.1016\/j.pharmthera.2019.107451","volume":"206","author":"GANAPATHYV BROWN T P","year":"2020","unstructured":"Brown T P Ganapathy V. Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon [J]. Pharmacol Ther. 2020;206:107451.","journal-title":"Pharmacol Ther"},{"issue":"Pt B","key":"11982_CR27","doi-asserted-by":"publisher","first-page":"115919","DOI":"10.1016\/j.jep.2022.115919","volume":"302","author":"X WANG","year":"2023","unstructured":"Wang X, Huang S, Zhang M, et al. Gegen Qinlian decoction activates AhR\/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice [J]. J Ethnopharmacol. 2023;302(Pt B):115919.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"11982_CR28","first-page":"224","volume":"44","author":"M YANG Y H, LIU","year":"2021","unstructured":"Yang Y H, Liu M, Jin X M, et al. Research progress of renal cell carcinoma and dysregulated amino acid metabolism [J]. Int J Immunol. 2021;44(2):224\u201331.","journal-title":"Int J Immunol"},{"key":"11982_CR29","doi-asserted-by":"publisher","first-page":"40146","DOI":"10.1038\/srep40146","volume":"7","author":"L WANG","year":"2017","unstructured":"Wang L, Liu S, Yang W, et al. Plasma amino Acid Profile in patients with aortic dissection [J]. Sci Rep. 2017;7:40146.","journal-title":"Sci Rep"},{"issue":"2","key":"11982_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3892\/ol.2023.13944","volume":"26","author":"ZHUFU X","year":"2023","unstructured":"Zhufu X. Metabolomic analysis of gut metabolites in patients with colorectal cancer: Association with disease development and outcome [J]. Oncol Lett. 2023;26(2):358.","journal-title":"Oncol Lett"},{"issue":"1","key":"11982_CR31","doi-asserted-by":"publisher","first-page":"165966","DOI":"10.1016\/j.bbadis.2020.165966","volume":"1867","author":"J CHENG","year":"2021","unstructured":"Cheng J, Liu Q, Jin H, et al. Integrating transcriptome and metabolome variability to reveal pathogenesis of esophageal squamous cell carcinoma [J]. Biochim Biophys Acta Mol Basis Dis. 2021;1867(1):165966.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"7","key":"11982_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"YUJ WONG C C","year":"2023","unstructured":"Wong C C Yu J. Gut microbiota in colorectal cancer development and therapy [J]. Nat Rev Clin Oncol. 2023;20(7):429\u201352.","journal-title":"Nat Rev Clin Oncol"},{"issue":"24","key":"11982_CR33","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.3748\/wjg.v27.i24.3609","volume":"27","author":"LIUF YANG Z-H","year":"2021","unstructured":"Yang Z-H Liuf, Zhu X-R, et al. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis [J]. World J Gastroenterol. 2021;27(24):3609\u201329.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"11982_CR34","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1080\/19490976.2020.1732268","volume":"11","author":"Y TIAN","year":"2020","unstructured":"Tian Y, Gui W, Koo I, et al. The microbiome modulating activity of bile acids [J]. Gut Microbes. 2020;11(4):979\u201396.","journal-title":"Gut Microbes"},{"key":"11982_CR35","volume-title":"Ketone body p-hydroxybutyrate ameliorates colitis by promoting M2 macrophge polarization through the STAT6-dependent signaling pathway [","author":"HUANG C Y","year":"2022","unstructured":"Huang C Y. Ketone body p-hydroxybutyrate ameliorates colitis by promoting M2 macrophge polarization through the STAT6-dependent signaling pathway [. Guangdong, China: D]; Southern Medical University; 2022."},{"issue":"3","key":"11982_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41568-022-00543-5","volume":"23","author":"GUERTIN D A","year":"2023","unstructured":"Guertin D A, Wellen K E. Acetyl-CoA metabolism in cancer [J]. Nat Rev Cancer. 2023;23(3):156\u201372.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"11982_CR37","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1016\/j.cmet.2021.11.010","volume":"33","author":"STPAULM SAIBIL S D","year":"2021","unstructured":"Saibil S D Stpaulm, Han S, et al. Coenzyme a fuels T cell anti-tumor immunity [J]. Cell Metabol. 2021;33(12):2415\u201327e6.","journal-title":"Cell Metabol"},{"key":"11982_CR38","doi-asserted-by":"crossref","unstructured":"Song Q, Wu J Z, Wang S. Postoperative Monocyte Count Change Is a Better Predictor of Survival Than Preoperative Monocyte Count in Esophageal Squamous Cell Carcinoma [J]. Biomed Res Int, 2019, 2019: 2702719.","DOI":"10.1155\/2019\/2702719"},{"issue":"7","key":"11982_CR39","doi-asserted-by":"publisher","first-page":"650","DOI":"10.2174\/0929867323666160119094313","volume":"23","author":"S SAKKAL","year":"2016","unstructured":"Sakkal S, Miller S, Apostolopoulos V, et al. Eosinophils in Cancer: favourable or unfavourable? [J]. Curr Med Chem. 2016;23(7):650\u201366.","journal-title":"Curr Med Chem"},{"issue":"1","key":"11982_CR40","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12967-022-03598-y","volume":"20","author":"C WU","year":"2022","unstructured":"Wu C, Qiu Y, Zhang R, et al. Association of peripheral basophils with tumor M2 macrophage infiltration and outcomes of the anti-PD-1 inhibitor plus chemotherapy combination in advanced gastric cancer [J]. J Transl Med. 2022;20(1):386.","journal-title":"J Transl Med"},{"key":"11982_CR41","doi-asserted-by":"publisher","first-page":"1056838","DOI":"10.3389\/fimmu.2022.1056838","volume":"13","author":"R POTO","year":"2022","unstructured":"Poto R, Gambardella A R, Marone G, et al. Basophils from allergy to cancer [J]. Front Immunol. 2022;13:1056838.","journal-title":"Front Immunol"},{"key":"11982_CR42","doi-asserted-by":"crossref","unstructured":"Chauhan J, Stavraka C, Grandits M et al. Clinical and translational significance of basophils in patients with Cancer [J]. Cells, 2022;11(3).","DOI":"10.3390\/cells11030438"},{"issue":"8","key":"11982_CR43","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1099\/jmm.0.000754","volume":"67","author":"Y LIU","year":"2018","unstructured":"Liu Y, Lin Z, Lin Y, et al. Streptococcus and Prevotella are associated with the prognosis of oesophageal squamous cell carcinoma [J]. J Med Microbiol. 2018;67(8):1058\u201368.","journal-title":"J Med Microbiol"},{"key":"11982_CR44","doi-asserted-by":"publisher","first-page":"1165790","DOI":"10.3389\/fcimb.2023.1165790","volume":"13","author":"S ZHANG","year":"2023","unstructured":"Zhang S, Zhang S, Ma X, et al. Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients [J]. Front Cell Infect Microbiol. 2023;13:1165790.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-11982-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-11982-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-11982-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T13:07:48Z","timestamp":1708607268000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-11982-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["11982"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-11982-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]},"assertion":[{"value":"4 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Changzhi Medical College, Shanxi Province, China, conducted the ethical review and approved this study (RT2021148).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}